Tag archives


Publisher: STRIVE

The past two decades have seen significant progress in tackling HIV. Behavioural interventions have curbed rates of transmission. The scale up of HIV treatment has not only reduced levels of morbidity and mortality, but also created new opportunities for HIV prevention. However, mathematical modelling suggests that, with the current rate of antiretroviral therapy (ART) initiation, 49 million more new HIV infections will occur by 2035, and that even at best, with 90 to 95% coverage, treatment will avert only 60% of new infections.

This entry was posted in and tagged on by .

Publisher:  Institute for Health Metrics and Evaluation

This 10th edition of the Institute for Health Metrics and Evaluation’s annual Financing Global Health report provides the most up-to-date estimates of development assistance for health, domestic spending on health, health spending on two key infectious diseases – malaria and HIV/AIDS – and future scenarios of health spending. Several transitions in global health financing inform this report: the influence of economic development on the composition of health spending; the emergence of other sources of development assistance funds and initiatives; and the increased availability of disease-specific funding data for the global health community. For funders and policymakers with sights on achieving 2030 global health goals, these estimates are of critical importance. They can be used for identifying funding gaps, evaluating the allocation of scarce resources, and comparing funding across time and countries.

This entry was posted in and tagged , , on by .

Publisher: Journal of the American Medical Association

In 2015, member states of the United Nations adopted the ambitious Sustainable Development Goals (SDGs), which included 17 global goals that targeted economic and social development.1 Goal 3, “to ensure healthy lives and promote well-being for all at all ages,” targets specifically marked progress in universal health coverage; improved access to safe, effective, and affordable medicines; and the end of the HIV, malaria, and tuberculosis epidemics by 2030.

This entry was posted in and tagged , , , on by .

Guest Blog Post:  Osservatorio AiDS – Aids Diritti Salute

Pictures are said to “speak more than a thousand words”. In order to document the impact of interventions to fight HIV and AIDS and to promote the right to access to medicines in Burkina Faso,  Osservatorio AiDS (Italian Network on AIDS, Rights and Health) together with its NGO member AIDOS (Association for Women in Development) engaged photographer Francesco Cocco to tell the story of the work done by The Global Fund and other organizations in the country.  In addition to visiting hospitals, Francesco also documented civil society organizations fighting gender-based violence (GBV), issues impacting minors and forced marriages.

This entry was posted in Blog and tagged on by .

Publisher: APMG Health, Inc. for GFAN

In 2017, the Global Fund contracted APMG Health to conduct assessments of the design, implementation, and monitoring of national HIV service packages for KP in 65 countries, across six regions in which the Global Fund has provided HIV grant funds. This report is a global-level analysis of those assessments.

This entry was posted in and tagged , , on by .

Publisher: HRI & Frontline AIDS

“Harm reduction interventions for people who use drugs—such as needle and syringe programmes (NSP) and opioid
substitution therapy (OST)—are cost-effective, protect against HIV and hepatitis C, and save lives. Harm reduction is explicitly
mentioned in one of the five combination prevention pillars endorsed by the Global HIV Prevention Coalition”

This entry was posted in and tagged , on by .